Center for Health Economics of Treatment Interventions for Substance Use Disorder, HCV, and HIV

Funded by the National Institute on Drug Abuse as a Center of Excellence

Learn about us Publications & Presentations Subscribe
Center for Health Economics of Treatment for Substance Users Is Established at Weill Cornell Medical College Read more

In response to the growing opioid epidemic in the United States there is an increased focus on expanding evidence-based treatment using medications prescribed for substance use disorder, especially medications that can be prescribed in outpatient settings including buprenorphine and naltrexone. The Surgeon General’s report on facing addiction in America describes substance use disorders as chronic […]

Read the full story

Photos: Megan Pellegrino In the opening plenary panel of the CHERISH (Center for Health Economics Treatment Interventions for Substance Use Disorder, HCV and HIV) conference on evidence-based policy and practice are (l to r) Daniel Polsky, PhD, moderator and Executive Director of the University of Pennsylvania’s Leonard Davis Institute of Health Economics (LDI); Tom McLellan, […]

Read the full story

Dr. Schackman will describe types of health economics research relevant to substance use disorders and co-occurring conditions, how health economics can be incorporated into clinical trials of screening and treatment interventions, and how health economics researchers can collaborate with substance use disorder researchers conducting observational and implementation studies. Examples will be drawn from Dr. Schackman’s […]

Read more


Philadelphia Task Force Issues Report on Opioids

by Kara Freeman and Janet Weiner, PhD, MPH

The opioid epidemic is a national problem, but solutions may be local. In Philadelphia, the Mayor’s Task Force to Combat the Opioid Epidemic recently released a reportwith 18 recommendations for a “comprehensive and coordinated plan to reduce opioid use disorder and its associated morbidity and mortality.” The report focuses on Philadelphia, but draws on data […]

Read the blog post

In a recent report, the CDC tracks drug overdose deaths in the US between 1999-2015.  The trends are not exactly what you might expect. Yes, given the recent press attention to the US opioid epidemic, the rates are predictable in that they are unacceptably high and increasing at a shocking rate. Age-adjusted drug overdose rates […]

Read the blog post


Experts in cost benefit, cost effectiveness, and budget impact analyses

Learn More Consultation Request


Experts in economic analysis of HCV and HIV and treatment among substance users

Learn More Consultation Request

Dissemination and Policy

Experts in disseminating health economic research among policy makers and the public

Learn More Latest Issue Brief

Pilot Grant and Training

Supports new investigators and investigators new to health economic research in substance use disorders, HCV, and HIV

Learn More Pilot Grants